Head of Theranostics Strategy Portfolio & Business Development (f/m/d)

Head of Theranostic Strategy Portfolio & Business Development

Siemens Healthineers Radiopharma

Location: France – Saint‑Genis‑Pouilly (01), Saint‑Cloud (92) or Lisses (91); Italy – Ivrea.

Role Summary

Lead the global theranostics strategy, encompassing both diagnostic and therapeutic radiopharmaceuticals, and develop external partnerships, including Radioligand Therapy (RLT) contracts for development and manufacturing (CDMO). The position drives end‑to‑end portfolio development, manufacturing network strategy, clinical and commercial supply readiness, and financial performance, acting as interface between commercial, technical operations, and external partners.

Key Responsibilities

• Define and execute the global theranostics strategy aligned with the Radiopharma business objectives.
• Identify, prioritize, and manage theranostics opportunities, including diagnostic and therapeutic radiopharmaceuticals, new isotopes, and emerging technologies.
• Develop long‑term portfolio roadmaps and investment strategies.
• Monitor market trends, competitive landscape, and regulatory developments.
• Define requirements and specificities to develop a global manufacturing and supply network to support theranostics programs.
• Define site strategy, capacity planning, and investment roadmap for theranostic products, ensuring alignment and collaboration with technical operations, quality, and capital programs functions.
• Ensure manufacturing capabilities support clinical trial and commercial supply requirements.
• Align network design with regulatory, quality, and logistical constraints.
• Lead business development activities with pharmaceutical, biotech, and academic partners.
• Position Siemens Healthineers Radiopharma as a CDMO and strategic partner for theranostics development and manufacturing.
• Structure and negotiate agreements for clinical trials and commercial supply.
• Support due diligence, valuation, and contract negotiations.
• Develop and manage business cases, financial models, and investment proposals.
• Define pricing strategies and commercial frameworks for partnerships.
• Monitor financial performance, including revenue, margin, and return on investment.
• Support budgeting and long‑term planning processes.

Travel

Required to perform job function (up to 50%).

Qualifications

• Advanced degree in Life Sciences, Engineering, Business, or related field (MBA preferred).
• 10–15 years’ experience in radiopharmaceuticals, oncology, nuclear medicine, or related industries, with exposure to radioligand therapy development.
• Strong knowledge of GMP manufacturing, clinical development, and radiopharmaceutical supply chains.
• Proven experience in business development, portfolio management, or strategic roles.
• Strong strategic, financial, and commercial acumen, including business case development and deal negotiations.
• Ability to lead complex, cross‑functional initiatives in a dynamic and evolving environment.

Job Dimensions

• Direct Reports: 0
• Geographic Scope: United Kingdom, EMEA & APAC Region.
• Reporting Lines: Managing Director (UK, EMEA & APAC).
• Impact on Organization: High; pivotal to the success of Radiopharma expansion strategy.

As an equal opportunity employer, we welcome applications from individuals with disabilities.